Viela Bio (VIE) Tops Q2 EPS by 35c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Viela Bio (VIE) Tops Q2 EPS by 35c

Viela Bio Reports Second Quarter 2020 Financial Results and Program Highlights

August 12, 2020 4:16 PM EDT

Company to host investor conference call and webcast today at 5:00 pm ET

GAITHERSBURG, Md., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq: VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, today reported financial results and provided program highlights for the second quarter ended June 30, 2020.

Viela had another productive quarter marked by the U.S. FDA approval of UPLIZNAalso known as inebilizumabin the U.S., said Bing Yao, Ph.D., Chief Executive Officer at Viela Bio. In parallel, we... More